D-0429-2019 Class III Terminated
FDA drug recall D-0429-2019 was initiated by Lupin Pharmaceuticals Inc. on Jan 28, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities. The recall status is terminated (terminated Jun 22, 2020). Affected quantity: 9,930 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 13, 2019
- Initiation Date
- Jan 28, 2019
- Termination Date
- Jun 22, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,930 bottles
Product description
Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles, Rx only, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA.
Reason for recall
Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.
Distribution pattern
Nationwide within the United States.
Code information
a) H804506 Exp. 06/2020; 803555 Exp. 04/2020; H805394, Exp. 08/2020 b) H804112 Exp. 05/2020; H803220 Exp. 03/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0429-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026